Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.
3.

Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.

Choi SH, Baek JH, Lee JH, Choi YJ, Song DE, Chung KW, Kim TY, Shong YK.

Thyroid. 2015 Aug;25(8):897-903. doi: 10.1089/thy.2014.0606. Epub 2015 Jul 8.

PMID:
25978151
4.
5.
6.

Malignancy risk and characteristics of thyroid nodules with two consecutive results of atypia of undetermined significance or follicular lesion of undetermined significance on cytology.

Park VY, Kim EK, Kwak JY, Yoon JH, Moon HJ.

Eur Radiol. 2015 Sep;25(9):2601-7. doi: 10.1007/s00330-015-3668-5. Epub 2015 Mar 5.

PMID:
25740802
7.

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.

Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, Tublin ME, Stang MT, Johnson JT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L.

Surgery. 2013 Oct;154(4):730-6; discussion 736-8. doi: 10.1016/j.surg.2013.05.015.

PMID:
24074409
8.

Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS).

Ho AS, Sarti EE, Jain KS, Wang H, Nixon IJ, Shaha AR, Shah JP, Kraus DH, Ghossein R, Fish SA, Wong RJ, Lin O, Morris LG.

Thyroid. 2014 May;24(5):832-9. doi: 10.1089/thy.2013.0317. Epub 2014 Mar 10.

9.

Reclassification of cytologically atypical thyroid nodules based on radiologic features in pediatric patients.

Arva NC, Deitch SG.

J Pediatr Endocrinol Metab. 2015 Jul;28(7-8):753-60. doi: 10.1515/jpem-2014-0427.

PMID:
25879311
10.
11.

Radiologic and clinical predictors of malignancy in the follicular lesion of undetermined significance of the thyroid.

Carr R, Ustun B, Chhieng D, Schofield K, Theoharis C, Hammers L, Adeniran AJ.

Endocr Pathol. 2013 Jun;24(2):62-8. doi: 10.1007/s12022-013-9240-4.

PMID:
23595630
12.

Follow-up of atypia and follicular lesions of undetermined significance in thyroid fine needle aspiration cytology.

Dincer N, Balci S, Yazgan A, Guney G, Ersoy R, Cakir B, Guler G.

Cytopathology. 2013 Dec;24(6):385-90. doi: 10.1111/cyt.12021. Epub 2012 Oct 18. Review.

PMID:
23078633
13.

Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).

Yoon JH, Kwon HJ, Kim EK, Moon HJ, Kwak JY.

Clin Endocrinol (Oxf). 2016 Aug;85(2):275-82. doi: 10.1111/cen.12987. Epub 2016 Jan 26.

PMID:
26639612
14.

Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS).

Kuru B, Atmaca A, Tarim IA, Kefeli M, Topgul K, Yoruker S, Elmali M, Danaci M.

Eur J Surg Oncol. 2016 Jan;42(1):87-93. doi: 10.1016/j.ejso.2015.09.026. Epub 2015 Oct 19.

PMID:
26527545
16.

Triage of patients with AUS/FLUS on thyroid cytopathology: effectiveness of the multimodal diagnostic techniques.

Kim TH, Jeong DJ, Hahn SY, Shin JH, Oh YL, Ki CS, Kim JW, Jang JY, Cho YY, Chung JH, Kim SW.

Cancer Med. 2016 May;5(5):769-77. doi: 10.1002/cam4.636. Epub 2016 Jan 18.

17.

RAS Mutations in AUS/FLUS Cytology: Does it Have an Additional Role in BRAFV600E Mutation-Negative Nodules?

Yoon JH, Kwon HJ, Lee HS, Kim EK, Moon HJ, Kwak JY.

Medicine (Baltimore). 2015 Jul;94(27):e1084. doi: 10.1097/MD.0000000000001084.

18.

A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration.

Yoon JH, Lee HS, Kim EK, Moon HJ, Kwak JY.

Surgery. 2014 Jun;155(6):1006-13. doi: 10.1016/j.surg.2013.12.035. Epub 2014 Jan 3.

PMID:
24630147
19.

Malignancy rate of thyroid nodules defined as follicular lesion of undetermined significance and atypia of undetermined significance in thyroid cytopathology and its relation with ultrasonographic features.

Çuhaci N, Arpaci D, Üçler R, Yazgan AK, Kıyak G, Yalçin S, Ersoy PE, Güler G, Ersoy R, Çakir B.

Endocr Pathol. 2014 Sep;25(3):248-56. doi: 10.1007/s12022-014-9298-7.

PMID:
24532158
20.

Supplemental Content

Support Center